| 000 | 01364 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517181145.0 | ||
| 264 | 0 | _c20190910 | |
| 008 | 201909s 0 0 eng d | ||
| 022 | _a2472-5560 | ||
| 024 | 7 |
_a10.1177/2472555217737006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHaikarainen, Teemu | |
| 245 | 0 | 0 |
_aDevelopment of an Inhibitor Screening Assay for Mono-ADP-Ribosyl Hydrolyzing Macrodomains Using AlphaScreen Technology. _h[electronic resource] |
| 260 |
_bSLAS discovery : advancing life sciences R & D _c03 2018 |
||
| 300 |
_a255-263 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aADP-Ribosylation _xdrug effects |
| 650 | 0 | 4 |
_aAdenosine Diphosphate Ribose _xmetabolism |
| 650 | 0 | 4 |
_aBiological Assay _xmethods |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGlycoside Hydrolases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrolysis _xdrug effects |
| 650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
| 650 | 0 | 4 |
_aProteins _xmetabolism |
| 700 | 1 | _aMaksimainen, Mirko M | |
| 700 | 1 | _aObaji, Ezeogo | |
| 700 | 1 | _aLehtiö, Lari | |
| 773 | 0 |
_tSLAS discovery : advancing life sciences R & D _gvol. 23 _gno. 3 _gp. 255-263 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/2472555217737006 _zAvailable from publisher's website |
| 999 |
_c27681198 _d27681198 |
||